FindTrial
Sign In

Discovery of biomarkers in the diagnosis and treatment of endometrial cancer

Discovery of biomarkers in the diagnosis and treatment of endometrial cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014658
Enrollment
Unknown
Registered
2018-01-26
Start date
2018-01-26
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Gold Standard:Histology diagnosis
Index test:levels&#32
of&#32
estrogen&#32
and&#32
its&#32
toxic&#32
metabolites&#32
the&#32
expression&#32
phase&#32
II&#32
metabolic&#32
enzymes&#32
UGT

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Disease group inclusion criteria: women with primary endometrial cancer. Healthy control group Selection criteria: healthy women with an age matched to the disease group, no history of cancer, good self-reported health.

Exclusion criteria

Exclusion criteria: Tobacco, alcohol and other substance abuse history; a clear diagnosis of type II diabetes mellitus; severe hypertension; long-term use of hormone drugs; nearly 5 years of gynecological malignancies.

Design outcomes

Primary

MeasureTime frame
E2, 2OHE2 and 4OHE2;—

Countries

China

Contacts

Public ContactXiaoxing Yin; Bei Zhang

Xuzhou Medical University

yinxx@xzhmu.edu.cn+86 13605218523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026